1-[2-(4-BENZYL-4-HYDROXY-PIPERIDIN-1-YL)-ETHYL]-3-(2-METHYL-QUINOLIN-4-YL)-UREA AS CRYSTALLINE SULFATE SALT - Patent 1802604

(19)

(11)

EP 1 802 604 A1

(12)

(43)	Date of publication:
	04.07.2007 Bulletin 2007/27

(21)	Application number: 05792250.2

(22)	Date of filing: 11.10.2005

(51)

International Patent Classification (IPC):

C07D 401/12^(2006.01)
A61P 9/02^(2006.01)

A61K 31/4709^(2006.01)

(86)	International application number:
	PCT/IB2005/053340

(87)	International publication number:
	WO 2006/040728 (20.04.2006 Gazette 2006/16)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

12.10.2004 WO PCT/EP2004/011410

(71)	Applicant: Actelion Pharmaceuticals Ltd.
	4123 Allschwil (CH)

(72)	Inventors:
	REDEY, Stephane F-68200 Mulhouse (FR) BUCHMANN, Stephan CH-4056 Basel (CH) BONARD, Jean Michel F-69100 Villeurbanne (FR) WOINET, Bertrand F-69006 Lyon (FR)

(74)	Representative: Ruhlmann, Eric
	Actelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 Allschwil 4123 Allschwil (CH)

(54)	1-[2-(4-BENZYL-4-HYDROXY-PIPERIDIN-1-YL)-ETHYL]-3-(2-METHYL-QUINOLIN-4-YL)-UREA AS CRYSTALLINE SULFATE SALT